As showed in Figure 6, we found higher GALE, RPL39L, PCDHB3, GUCA1A, MICALL2, SLC35G5, MGMT, TSPAN4, NOL3 and NLRP12 expression are correlated with poor overall survival in GBM patients (Figure 6(B,G–O)). This evidence concerns the gene MICALL2 and glioblastoma.